WallStreetZenWallStreetZen

NYSE: ABT
Abbott Laboratories Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Abbott Laboratories earnings were $6.5B for the trailing 12 months ending Dec 31, 2025, with -51.4% growth year over year. The latest ABT earnings report on Dec 31, 2025 announced Q4 2025 earnings of $1.8B, up 8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ABT reported annual earnings of $6.5B, with -51.3% growth.

ABT past earnings growth

How has ABT's earnings growth performed historically?

Company
-51.37%
Industry
25.24%
Market
86.97%
ABT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ABT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ABT's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ABT earnings history

Current Revenue
$44.3B
Current Earnings
$6.5B
Current Profit Margin
14.7%
ABT's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ABT Return on Equity

Current Company
12.8%
Current Industry
8.8%
Current Market
28.9%
ABT's Return on Equity (12.8%)... subscribe to Premium to read more.
High Return on Equity Performance

ABT Return on Assets

Current Company
7.8%
Current Industry
5.4%
ABT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ABT announces earnings.

ABT Return on Capital Employed

Current Company
12.76%
Current Industry
9.4%
ABT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ABT vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ABT$12.08B$6.52B+8.16%$3.73
SYK$5.58B$3.25B+14.79%$8.49
MDT$9.33B$4.61B+10.96%$3.60
BSX$5.11B$2.90B+29.82%$1.96
EW$1.49B$1.07B+6.87%$1.84
View Top Medical Device Stocks

Abbott Laboratories Earnings Reports & History FAQ

What were Abbott Laboratories's earnings last quarter?

On ABT's earnings call on Invalid Date, Abbott Laboratories (NYSE: ABT) reported Q4 2025 earnings per share (EPS) of $1.01, up 80.87% year over year. Total ABT earnings for the quarter were $1.78 billion. In the same quarter last year, Abbott Laboratories's earnings per share (EPS) was $5.28.

If you're new to stock investing, here's how to buy Abbott Laboratories stock.

Is Abbott Laboratories profitable or losing money?

As of the last Abbott Laboratories earnings report, Abbott Laboratories is currently profitable. Abbott Laboratories's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $6.52 billion, a 51.32% decrease year over year.

What was ABT's earnings growth in the past year?

As of Abbott Laboratories's earnings date in Invalid Date, Abbott Laboratories's earnings has grown -51.37% year over year. This is 76.61 percentage points lower than the US Medical Devices industry earnings growth rate of 25.24%. ABT earnings in the past year totalled $6.52 billion.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.